{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T20:41:54Z","timestamp":1648932114813},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.medcli.2011.11.026","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T12:25:42Z","timestamp":1327753542000},"page":"379-384","source":"Crossref","is-referenced-by-count":1,"title":["Comparaci\u00f3n de los pacientes de un registro espa\u00f1ol de enfermedad de Fabry en dos periodos de tiempo"],"prefix":"10.1016","volume":"139","author":[{"given":"Miguel \u00c1ngel","family":"Barba Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Rivera Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillem","family":"Pintos Morell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2011.11.026_bib0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2011.11.026_bib0010","series-title":"Diagn\u00f3stico y tratamiento de las enfermedades metab\u00f3licas hereditarias","first-page":"847","article-title":"Enfermedad de Fabry","author":"Rodr\u00edguez-Palmero Seuma","year":"2010"},{"key":"10.1016\/j.medcli.2011.11.026_bib0015","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0020","first-page":"30","article-title":"The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease","volume":"102","author":"Konreich","year":"1989","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.medcli.2011.11.026_bib0025","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0030","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2011.11.026_bib0035","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural History of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2011.11.026_bib0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.gim.0000223545.63012.5a","article-title":"Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population and patients with other chronic disease","volume":"8","author":"Street","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2011.11.026_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2011.11.026_bib0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus L.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.medcli.2011.11.026_bib0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.a.30123","article-title":"Inheritance of most X-linked traits is not dominant or recessive, just X-linked","volume":"129A","author":"Dobyns","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.medcli.2011.11.026_bib0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Gen"},{"key":"10.1016\/j.medcli.2011.11.026_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0075","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2011.11.026_bib0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A-replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2011.11.026_bib0085","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/GIM.0b013e3181f13b75","article-title":"Effects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature","volume":"12","author":"Lidove","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2011.11.026_bib0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1157\/13093265","article-title":"Enfermedad de Fabry en Espa\u00f1a: primer an\u00e1lisis de la respuesta al tratamiento de sustituci\u00f3n enzim\u00e1tica","volume":"127","author":"Rivera Gallego","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.11.026_bib0095","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.medcli.2011.11.026_bib0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1756 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2011.11.026_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1157\/13063178","article-title":"Enfermedad de Fabry en Espa\u00f1a. An\u00e1lisis de 24 casos","volume":"123","author":"Barba","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2011.11.026_bib0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1742-1241.2011.02695.x","article-title":"Fabry disease in Spain. Description of Spanish patients and a comparison with other European countries using data from the Fabry Outcome Survey (FOS)","volume":"65","author":"Barba-Romero","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.medcli.2011.11.026_bib0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1399-0004.2004.00219.x","article-title":"The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy","volume":"65","author":"Whybra","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0120","unstructured":"PubMed [consultado el 20 Nov 2011]. Disponible en: http:\/\/www.ncbi.nlm.nih.gov\/sites\/pubmed"},{"issue":"Supl 3","key":"10.1016\/j.medcli.2011.11.026_bib0125","first-page":"1","article-title":"La enfermedad de Fabry como modelo de enfermedad multisist\u00e9mica","volume":"206","author":"Barbado Hern\u00e1ndez","year":"2006","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.medcli.2011.11.026_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1651-2227.2008.00649.x","article-title":"Early therapeutic intervention in females with Fabry disease","volume":"97","author":"Hughes","year":"2008","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.medcli.2011.11.026_bib0135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1399-0004.2009.01345.x","article-title":"Does geographical location influence de phenotype of Fabry disease in women in Europe?","volume":"77","author":"Barba-Romero","year":"2010","journal-title":"Clin Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0140","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-136-8-200204160-00010","article-title":"Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition","volume":"136","author":"Remuzzi","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.medcli.2011.11.026_bib0145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ahj.2004.04.037","article-title":"Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"148","author":"Kjeldsen","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.medcli.2011.11.026_bib0150","article-title":"Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey","author":"Ramaswami","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.medcli.2011.11.026_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10897-007-9128-x","article-title":"Diagnosis of Fabry disease via analysis of family history","volume":"17","author":"Laney","year":"2008","journal-title":"J Genet Couns"},{"key":"10.1016\/j.medcli.2011.11.026_bib0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.medcli.2011.02.024","article-title":"Consenso para el estudio y tratamiento de la enfermedad de Fabry. Fundaci\u00f3n GETER","volume":"137","author":"Garc\u00eda de Lorenzo","year":"2011","journal-title":"Med Clin (Barc)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775311011833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775311011833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T16:22:33Z","timestamp":1543249353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775311011833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0025775311011833"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2011.11.026","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}